Allstate (ALS) Stock Forecast & Price Target
ALS Analyst Ratings
ALS Stock 12 Month Forecast
Average Price Target
CHF 223.53▲(0.00% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Elyse Greenspan | Wells Fargo | CHF 192.83→CHF 205.91 | hold | ― | Assigned | 11/06/26 | ||
| Matthew Heimermann | Citi | CHF 175.68→CHF 183.85 | sell | ― | Reiterated | 11/06/26 | ||
| Yaron Kinar | Mizuho Securities | CHF 241.04→CHF 254.12 | buy | ― | Reiterated | 11/06/26 | ||
| Vikram Gandhi | HSBC | CHF 217.35→CHF 221.43 | hold | ― | Downgraded | 11/06/26 | ||
| Alex Scott | Barclays | CHF 180.58→CHF 186.30 | sell | ― | Reiterated | 11/05/26 | ||
| Robert Cox CFA | Goldman Sachs | CHF 204.27→CHF 224.70 | hold | ― | Reiterated | 11/05/26 | ||
| David Motemaden | Evercore ISI | CHF 214.08→CHF 219.80 | hold | ― | Reiterated | 11/05/26 | ||
| Paul Newsome | Piper Sandler | CHF 245.13 | buy | ― | Reiterated | 11/05/26 | ||
| Joshua Shanker | Bank of America Securities | CHF 277.81→CHF 302.33 | buy | ― | Reiterated | 11/04/26 | ||
| Brian Meredith | UBS | CHF 224.70 | hold | ― | Assigned | 10/20/26 | ||
| Meyer Shields | KBW | CHF 189.57 | sell | ― | Reiterated | 10/16/26 | ||
| Bob Huang | Morgan Stanley | CHF 196.10 | hold | ― | Assigned | 10/16/26 | ||
| Kevin Heal | Argus Research | CHF 194.47 | hold | ― | Downgraded | 08/27/26 | ||
| Michael Zaremski | BMO Capital | CHF 204.27→CHF 232.05 | buy | ― | Assigned | 08/13/26 | ||
| Pablo Singzon | J.P. Morgan | CHF 230.42→CHF 238.59 | buy | ― | Reiterated | 08/11/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Elyse GreenspanWells Fargo | HoldAssignedCHF 192.83→CHF 205.91 | 11/06/26 | ― | ||
| Matthew HeimermannCiti | SellReiteratedCHF 175.68→CHF 183.85 | 11/06/26 | ― | ||
| Yaron KinarMizuho Securities | BuyReiteratedCHF 241.04→CHF 254.12 | 11/06/26 | ― | ||
| Vikram GandhiHSBC | HoldDowngradedCHF 217.35→CHF 221.43 | 11/06/26 | ― | ||
| Alex ScottBarclays | SellReiteratedCHF 180.58→CHF 186.30 | 11/05/26 | ― | ||
| Robert Cox CFAGoldman Sachs | HoldReiteratedCHF 204.27→CHF 224.70 | 11/05/26 | ― | ||
| David MotemadenEvercore ISI | HoldReiteratedCHF 214.08→CHF 219.80 | 11/05/26 | ― | ||
| Paul NewsomePiper Sandler | BuyReiteratedCHF 245.13 | 11/05/26 | ― | ||
| Joshua ShankerBank of America Securities | BuyReiteratedCHF 277.81→CHF 302.33 | 11/04/26 | ― | ||
| Brian MeredithUBS | HoldAssignedCHF 224.70 | 10/20/26 | ― | ||
| Meyer ShieldsKBW | SellReiteratedCHF 189.57 | 10/16/26 | ― | ||
| Bob HuangMorgan Stanley | HoldAssignedCHF 196.10 | 10/16/26 | ― | ||
| Kevin HealArgus Research | HoldDowngradedCHF 194.47 | 08/27/26 | ― | ||
| Michael ZaremskiBMO Capital | BuyAssignedCHF 204.27→CHF 232.05 | 08/13/26 | ― | ||
| Pablo SingzonJ.P. Morgan | BuyReiteratedCHF 230.42→CHF 238.59 | 08/11/26 | ― |
Best Analysts Covering Allstate
Copying Yaron Kinar's trades and holding each position for 3 Months would result in 85.71% of your transactions generating a profit, with an average return of +6.78% per trade.
Copying Yaron Kinar's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +19.45% per trade.
Copying Yaron Kinar's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +32.38% per trade.
ALS Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 14 | 19 | 22 | 20 | 11 |
| Hold | 18 | 22 | 20 | 16 | 13 |
| Sell | 5 | 9 | 8 | 10 | 7 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 37 | 50 | 50 | 46 | 31 |
In the current month, ALS has received 11 Buy Ratings, 13 Hold Ratings, and 7 Sell Ratings. ALS average Analyst price target in the past 3 months is 223.53.
ALS Financial Forecast
ALS Earnings Forecast
Next quarter’s earnings estimate for ALS is CHF 7.91 with a range of CHF 4.65 to CHF 10.05. The previous quarter’s EPS was CHF 8.01. Its overall industry beat the EPS estimate 81.82% of the time in the past 12 months.
ALS Sales Forecast
Next quarter’s sales forecast for ALS is CHF 12.31B with a range of CHF 12.25B to CHF 12.41B. The previous quarter’s sales results were CHF 14.23B. Its overall industry beat sales estimates 93.33% of the time in the past 12 months.
